In vitro pharmacologic testing using human induced pluripotent stem cell-derived cardiomyocytes.

Area of Science:

• Cardiovascular Research
• Stem Cell Biology
• Drug Discovery

Background:

• Torsade de pointes (TdP) is a lethal ventricular arrhythmia frequently causing drug withdrawal.
• A lack of reliable in vitro models for human cardiac cells impedes the detection of pro-arrhythmic drug effects.

Purpose of the Study:

• To investigate the potential of human induced pluripotent stem (hiPS) cells as a model for cardiac electrophysiology and drug screening.
• To assess the utility of hiPS-derived cardiomyocytes (hiPS-CMs) in detecting drug-induced arrhythmias.

Main Methods:

• hiPS cells were differentiated into functional cardiomyocytes (hiPS-CMs) expressing cardiac markers.
• hiPS-CMs were analyzed using a multi-electrode assay to evaluate electrophysiologic properties.
• The effects of ion channel inhibitors on hiPS-CMs were compared to native cardiomyocytes.

Main Results:

• hiPS-CMs expressed key cardiac markers (Nkx2.5, GATA4, atrial natriuretic peptide).
• Application of ion channel inhibitors induced dose-dependent changes in the field potential waveform of hiPS-CMs.
• These electrophysiologic changes mimicked those observed in native cardiomyocytes.

Conclusions:

• hiPS-derived cardiomyocytes represent a viable in vitro model for studying cardiac electrophysiology.
• This hiPS-CM model shows promise for screening drug candidates and identifying potential pro-arrhythmic effects.
• The model offers a valuable tool to mitigate drug withdrawal due to Torsade de pointes risk.